ADMET in silico modelling: towards prediction paradise?
- Published in:
- 2003
- By:
- Publication type:
- journal article
Works matching IS 14741776 AND DT 2003 AND VI 2 AND IP 3
Results: 23
1
2
A guide to drug discovery: Combinatorial compound libraries for drug discovery: an ongoing challenge.
- Published in:
- Nature Reviews Drug Discovery, 2003, v. 2, n. 3, p. 222, doi. 10.1038/nrd1035
- By:
- Publication type:
- Article
3
Opinion: Biotech's twentieth birthday blues.
- Published in:
- Nature Reviews Drug Discovery, 2003, v. 2, n. 3, p. 231, doi. 10.1038/nrd1036
- By:
- Publication type:
- Article
4
Eplerenone.
- Published in:
- 2003
- By:
- Publication type:
- journal article
5
Biotech's twentieth birthday blues.
- Published in:
- 2003
- By:
- Publication type:
- review
6
RNA-targeted drugs: The ESSENCE of correction.
- Published in:
- Nature Reviews Drug Discovery, 2003, v. 2, n. 3, p. 170, doi. 10.1038/nrd1029
- By:
- Publication type:
- Article
7
Innovation: Big physics, small doses: the use of AMS and PET in human microdosing of development drugs.
- Published in:
- Nature Reviews Drug Discovery, 2003, v. 2, n. 3, p. 233, doi. 10.1038/nrd1037
- By:
- Publication type:
- Article
8
Structure-based drug design: Can GPCR models work?
- Published in:
- Nature Reviews Drug Discovery, 2003, v. 2, n. 3, p. 171, doi. 10.1038/nrd1030
- By:
- Publication type:
- Article
9
Case history: Tamoxifen: a most unlikely pioneering medicine.
- Published in:
- Nature Reviews Drug Discovery, 2003, v. 2, n. 3, p. 205, doi. 10.1038/nrd1031
- By:
- Publication type:
- Article
10
Fresh from the pipeline: Eplerenone.
- Published in:
- Nature Reviews Drug Discovery, 2003, v. 2, n. 3, p. 177, doi. 10.1038/nrd1039
- By:
- Publication type:
- Article
11
Effect of pegylation on pharmaceuticals.
- Published in:
- Nature Reviews Drug Discovery, 2003, v. 2, n. 3, p. 214, doi. 10.1038/nrd1033
- By:
- Publication type:
- Article
12
Case history: The development of COX2 inhibitors.
- Published in:
- Nature Reviews Drug Discovery, 2003, v. 2, n. 3, p. 179, doi. 10.1038/nrd1034
- By:
- Publication type:
- Article
13
Cardiovascular disease: Metabonomics reveals blocked pipes.
- Published in:
- Nature Reviews Drug Discovery, 2003, v. 2, n. 3, p. 169, doi. 10.1038/nrd1048
- By:
- Publication type:
- Article
14
Allergy: Eliminating E from the class.
- Published in:
- Nature Reviews Drug Discovery, 2003, v. 2, n. 3, p. 173, doi. 10.1038/nrd1051
- By:
- Publication type:
- Article
15
From the analyst's couch: The painful reality.
- Published in:
- Nature Reviews Drug Discovery, 2003, v. 2, n. 3, p. 175
- By:
- Publication type:
- Article
16
Cancer: Parc keeper.
- Published in:
- Nature Reviews Drug Discovery, 2003, v. 2, n. 3, p. 174, doi. 10.1038/nrd1049
- By:
- Publication type:
- Article
17
Cardiovascular disease: Another string to LXR's bow.
- Published in:
- Nature Reviews Drug Discovery, 2003, v. 2, n. 3, p. 172, doi. 10.1038/nrd1050
- By:
- Publication type:
- Article
18
Inflammation: Targeting two for the price of one.
- Published in:
- Nature Reviews Drug Discovery, 2003, v. 2, n. 3, p. 170, doi. 10.1038/nrd1052
- By:
- Publication type:
- Article
19
CORRECTION: Therapeutic antibodies for human disease at the dawn of the twenty-first century.
- Published in:
- 2003
- By:
- Publication type:
- Erratum
20
Apoptosis: If I had a hammer...
- Published in:
- Nature Reviews Drug Discovery, 2003, v. 2, n. 3, p. 172, doi. 10.1038/nrd1053
- By:
- Publication type:
- Article
21
Patent Watch.
- Published in:
- Nature Reviews Drug Discovery, 2003, v. 2, n. 3, p. 174
- Publication type:
- Article
22
Analytical jobs for analytical minds.
- Published in:
- Nature Reviews Drug Discovery, 2003, v. 2, n. 3, p. 243, doi. 10.1038/nrd1058
- By:
- Publication type:
- Article
23
Follow the yellow brick road.
- Published in:
- 2003
- Publication type:
- Editorial